128 related articles for article (PubMed ID: 36645712)
1. Serum proteomics profiling identifies a preliminary signature for the diagnosis of early-stage lung cancer.
Gasparri R; Noberini R; Cuomo A; Yadav A; Tricarico D; Salvetto C; Maisonneuve P; Caminiti V; Sedda G; Sabalic A; Bonaldi T; Spaggiari L
Proteomics Clin Appl; 2023 Mar; 17(2):e2200093. PubMed ID: 36645712
[TBL] [Abstract][Full Text] [Related]
2. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
[TBL] [Abstract][Full Text] [Related]
3. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
4. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
5. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
6. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
7. Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis.
Gasparri R; Sedda G; Noberini R; Bonaldi T; Spaggiari L
Proteomics Clin Appl; 2020 Sep; 14(5):e1900138. PubMed ID: 32418314
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
9. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
[TBL] [Abstract][Full Text] [Related]
10. Identification of ENO1 as a potential sputum biomarker for early-stage lung cancer by shotgun proteomics.
Yu L; Shen J; Mannoor K; Guarnera M; Jiang F
Clin Lung Cancer; 2014 Sep; 15(5):372-378.e1. PubMed ID: 24984566
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
Hou Y; Guo H; Guo Y; Zhang Y; Han H
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
[TBL] [Abstract][Full Text] [Related]
12. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
13. A proteomic approach to the identification of lung cancer markers.
Hanash S; Brichory F; Beer D
Dis Markers; 2001; 17(4):295-300. PubMed ID: 11790896
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
[TBL] [Abstract][Full Text] [Related]
15. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
16. Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors.
Zhang C; Leng W; Sun C; Lu T; Chen Z; Men X; Wang Y; Wang G; Zhen B; Qin J
EBioMedicine; 2018 Apr; 30():120-128. PubMed ID: 29576497
[TBL] [Abstract][Full Text] [Related]
17. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
[TBL] [Abstract][Full Text] [Related]
18. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
Planque C; Kulasingam V; Smith CR; Reckamp K; Goodglick L; Diamandis EP
Mol Cell Proteomics; 2009 Dec; 8(12):2746-58. PubMed ID: 19776420
[TBL] [Abstract][Full Text] [Related]
19. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
20. PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.
Gámez-Pozo A; Sánchez-Navarro I; Calvo E; Agulló-Ortuño MT; López-Vacas R; Díaz E; Camafeita E; Nistal M; Madero R; Espinosa E; López JA; Fresno Vara JÁ
PLoS One; 2012; 7(3):e33752. PubMed ID: 22461895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
